Efficacy and safety of splenetomy on telaprevir-based triple therapy in chronic hepatitis C patients with thrombocytopenia

Trial Profile

Efficacy and safety of splenetomy on telaprevir-based triple therapy in chronic hepatitis C patients with thrombocytopenia

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Telaprevir (Primary) ; Antivirals
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Apr 2014 Planned End Date changed to 24 Mar 2014 as reported by University Hospital Medical Information Network - Japan
    • 24 Mar 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 25 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top